Canada markets open in 4 hours 5 minutes

Creso Pharma Ltd. (1X8.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.0237-0.0001 (-0.42%)
As of 08:04AM CEST. Market open.
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
6,218
6,218
2,448
3,626
558.382
Cost of Revenue
6,619
6,619
6,330
1,501
353.566
Gross Profit
-400.611
-400.611
-3,882
2,126
204.816
Operating Expenses
Research Development
-
-
344.989
286.026
286.539
Selling General and Administrative
10,189
10,189
4,245
6,745
12,074
Total Operating Expenses
27,952
27,952
10,486
12,301
14,969
Operating Income or Loss
-28,353
-28,353
-14,368
-10,175
-14,765
Interest Expense
1,706
1,706
9,269
2,090
432.216
Total Other Income/Expenses Net
28.447
28.447
-7,143
-3,132
-1,793
Income Before Tax
-30,031
-30,031
-30,780
-15,340
-16,846
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-30,031
-30,031
-30,780
-15,340
-16,846
Net Income
-30,031
-30,031
-30,780
-15,054
-16,756
Net Income available to common shareholders
-30,031
-30,031
-30,780
-15,054
-16,756
Basic EPS
-
-
-0.08
-0.10
-0.15
Diluted EPS
-
-
-0.08
-0.10
-0.15
Basic Average Shares
-
-
370,838
143,784
112,552
Diluted Average Shares
-
-
370,838
143,784
112,552
EBITDA
-
-28,058
-21,158
-12,848
-16,375